Epidemiology of Graves’ orbitopathy (GO) and relationship with thyroid disease

Lazarus, John H.·2012·Best Practice & Research Clinical Endocrinology & Metabolism
DOI 10.1016/j.beem.2011.10.005

Cited by (182)

Items 101–182 of 182

  1. Teprotumumab (Tepezza) for Thyroid Eye Disease.
    Steven M. Couch · 2022 · PubMed Central
  2. A retrospective study of clinical features and prognosis of patients with Graves’ disease and ophthalmopathy
    Zhong Ying Rui, Xue Yin, Xuan Wang, Jie Shen, Wei Zheng · 2022 · Nuclear Medicine Communications
  3. Thyroid Eye Disease: A Comprehensive Review
    Shannon S. Joseph, Raymond S. Douglas · 2015 · Essentials in ophthalmology/Essentials ophthalmology
  4. The change in the clinical presentation of Graves’ disease: a 30 years retrospective survey in an academic Brazilian tertiary center
    Wanesa Pinto, João Hamilton Romaldini, Nicolas Perini, Roberto Boettier dos Santos, Danilo Villagelin · 2020 · Archives of Endocrinology and Metabolism
  5. The role of PET/CT in thyroid autoimmune diseases
    Elena CALIFARETTI, Sara Dall’Armellina, Guido Rovera, Monica Finessi, Désirèe Deandreis · 2022 · The Quarterly Journal of Nuclear Medicine and Molecular Imaging
  6. Changes of mRNA expression underlying orbital adipogenesis in thyroid-associated orbitopathy
    Xiao Feng Bai, Xiao Chu, Tao Yang, Bo Tong, Xin Qi, Yang Peng, Yuan Li, Lu Wang, Yun Li · 2022 · Archives of Medical Science
  7. Altered functional connectivity strength of primary visual cortex in subjects with thyroid-associated ophthalmopathy
    Chen-Xing Qi, Zhi Wen, Xin Huang · 2024 · Neuroreport
  8. Changes in retinal nerve fibre layer, ganglion cell layer and visual function in eyes with thyroid eye disease of different severities with and without orbital decompression
    Jie Guo, Ruiqi Ma, Lu Gan, Xiaofeng Li, Kang Xue, Jin-Wei Cheng, Qian Jiang · 2022 · Eye
  9. Changing the face of thyroid eye disease
    Shoaib Ugradar, Robert A. Goldberg, Raymond S. Douglas · 2022 · Eye
  10. Prognostic factors for significant 6-month recovery in dysthyroid optic neuropathy in a tertiary center: A series of 69 eyes in 38 patients
    Victor Vermot-Desroches, Kim Thia-Soui-Tchong, Perrine Raymond, Andrea Filip, Jacques Orgiazzi, Emmanuel Jouanneau, Caroline Tilikete, Françoise Borson‐Chazot, Romain Manet, Juliette Abeillon du Payrat · 2023 · Annales d Endocrinologie
  11. Update endokrine Orbitopathie
    Anja Katrin Eckstein, Utta Berchner‐Pfannschmidt, Dagmar Führer, J. Esser · 2013 · Der Ophthalmologe
  12. A Validated Tool Can Predict Risk or Nonrisk of Graves’ Orbitopathy During Antithyroid Drug Treatment of Hyperthyroid Graves’ Disease
    Jacques Orgiazzi · 2018 · Clinical Thyroidology
  13. An update on thyroid eye disease: Current knowledge, preferred practice patterns, and future therapies
    Fairooz Puthiyapurayil Manjandavida, Shaifali Chahar · 2020 · Kerala Journal of Ophthalmology
  14. Dysthyroid Optic Neuropathy
    Ayushi Agarwal, Samreen Khanam · 2020 · StatPearls
  15. Long-term surgical outcome and impact on daily life activities of strabismus surgery in thyroid-associated ophthalmopathy with and without previous orbital decompression
    Matilde Roda, Nicola Valsecchi, Natalie di Geronimo, Andrea Repaci, Valentina Vicennati, Uberto Pagotto, Michela Fresina, Luigi Fontana, Costantino Schiavi · 2024 · Head & Face Medicine
  16. Correlation of Levator‐Muller's Complex Thickness on Ultrasound Biomicroscopy to Botulinum Toxin A Injection in Thyroid‐Related Upper Eyelid Retraction
    Sindhuja Kandasamy, Sahil Agrawal, Neelam Pushker, Rachna Meel, Mandeep Bajaj, Thirumurthy Velpandian, Viveka P. Jyotsna · 2022 · Journal of Ultrasound in Medicine
  17. Biomechanical changes of the cornea after orbital decompression in thyroid-associated orbitopathy measured by corvis ST
    Mahdi Soleymanzadeh, Seyed Mohsen Rafizadeh, Ghazal Ghochani, Amir Reza Mafi, Mohammadreza Nazari, Mohammad Taher Rajabi · 2024 · Scientific Reports
  18. Ophthalmic manifestations of thyroid disease and the association of serum levels of T3, T4 and TSH with thyroid eye disease
    Priyanka Choudhari, Ugam Usgaonkar, Dipti Shrivastav · 2019 · Tropical Journal of Ophthalmology and Otolaryngology
  19. Optic nerve injury in preoperative imaging is associated with visual improvement outcome in endoscopic optic nerve decompression
    Isabella Leitner, Alexandros Andrianakis, Verena Gellner, P Kiss, Damianos Andrianakis, Peter Valentin Tomazic · 2021 · Wiener klinische Wochenschrift
  20. Trends in Graves’ orbitopathy research in the past two decades: a bibliometric analysis
    Khaled Ali Elubous, Ali D. Alebous, Hebah A. Abous, Rawan A. Elubous, Lana A. Alebous, Taher Alshammari · 2021 · Arquivos Brasileiros de Oftalmologia
  21. A questionnaire survey on the management of Graves' orbitopathy in China: A comparison with Europe and Latin‐America
    Shuhang Xu, Xing‐Jia Li, Guofang Chen, Quanxi Zheng, Yang Yu, Yongxin Hu, Kun Wang, Chao Liu · 2015 · Chronic Diseases and Translational Medicine
  22. Correlation between thyroidal and peripheral blood total T cells, CD8+T cells, and CD8+T- regulatory cells and T-cell reactivity to calsequestrin and collagen XIII in patients with Graves’ ophthalmopathy
    Farah Al-Ansari, Hooshang Lahooti, Leanne Stokes, Senarath Edirimanne, Jack R. Wall · 2018 · Endocrine Research
  23. Antiphospholipid antibodies in patients with Graves’ orbitopathy: preliminary data
    Mirjana B. Bećarević, Marija Sarić Matutinović, Miloš Žarković, Biljana Nedeljkovic Beleslin, Jasmina Ćirić, Svetlana Ignjatović · 2021 · Endocrine
  24. Eye Conditions in Women
    Anne Wishna, Amanda Hurtig, Kimberly J. Templeton · 2020 · Gender and the Genome
  25. Clinical features, pathophysiology, and management of thyroid eye disease
    Hannah Schultz, Ava Niknahad, Jacob K. Sterling, Fatemeh Rajaii · 2023 · Minerva Ophthalmology
  26. Evaluating the Thyroid Eye Disease Patient
    Ksenia Denisova, Anne Barmettler · 2021 · International Ophthalmology Clinics
  27. Hyperthyroidism and Thyrotoxicosis
    Vahab Fatourechi · 2022 · Springer eBooks
  28. 12 Thyroid Ophthalmopathy
    2021 · Thieme Medical Publishers eBooks
  29. Epidemiology and Genetic Factors in Graves’ Disease and Graves’ Ophthalmopathy
    Sara Salehi Hammerstad, Yaron Tomer · 2015 · Springer eBooks
  30. The relationship between thyroid eye disease and radioiodine treatment
    Sarameth Thou, Sobhan Vinjamuri · 2019 · Nuclear Medicine Communications
  31. Acquired Strabismus and Diplopia as Initial Presentation Signs of Hyperthyroidism and Thyroid Eye Disease
    Seung Min Chung, Won Jae Kim · 2020 · Journal of the Korean Ophthalmological Society
  32. Graves Hastalığı ile Tnf- α, Galektin-3 ve Fibronektin Düzeylerinin İlişkisi
    Ayşe İrem Yasin, Mahmut Muzaffer Ilhan, Saime Turan, İlhan Yaylım, Özcan Karaman, Ertuğrul Taşan · 2020 · The Anatolian Journal of General Medical Research
  33. Successful Case of Teprotumumab Treatment in an Adolescent Patient With Thyroid Eye Disease
    Nicholas P. Radulovich, Alexandra J. van Brummen, Christopher B. Chambers, Matthew M. Zhang · 2024 · Ophthalmic Plastic and Reconstructive Surgery
  34. Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fibre Layer Changes in Patients With Thyroid Eye Disease Without Optic Neuropathy: A Retrospective Observational Study
    Shrinkhal, Aparajita Shukla, Pragati Garg, Nilakshi Banerjee, Pramod Kumar, Mukesh Shukla, Ruchi Shukla, Swarastra Prakash Singh · 2025 · Cureus
  35. TSHR‐Targeting Nucleic Acid Aptamer Treats Graves' Ophthalmopathy via Novel Allosteric Inhibition
    Yanchen Zhang, Ende Wu, Weibin Liu, Ling Zeng, Neng Ling, Hongmei Wang, Zhixing Li, Shuang Yao, Tonghe Pan, Xuanwen Li et al. · 2025 · Advanced Science
  36. The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI
    Xiaoli Yuan, Han Li, Feng Wang · 2026 · Frontiers in Medicine
  37. Favorable Effect of Bromocriptine and Pentoxifylline in Mild Graves Disease Orbitopathy: A Randomized, Open, Clinical Trial
    Francisco Cárdenas-Velázquez · 2017 · Journal of Endocrinology and Diabetes
  38. UDZIAŁ KOMÓREK IMMUNOLOGICZNYCH W PATOGENEZIE ORBITOPATII GRAVESA
    Anna Izabella Król · 2019 · Prospects in Pharmaceutical Sciences
  39. Afecciones tóxicas y endocrinas musculares
    T. Wirth, Emilie Fockens, H. De Cagny, Pierre Lafforgue, Sandrine Guis · 2022 · EMC - Aparato Locomotor
  40. Orbital Lymphoma Masquerading as Euthyroid Orbitopathy
    Muhammad Waqar Sharif, Sai Mungara, Kelash Bajaj, Pablo Amador, Nuvneet Khandelwal · 2023 · Cureus
  41. A rare form of hyperthyroidism leading to the diagnosis of acromegaly: A case report
    Iulia-Ștefania Plotuna, Melania Balaş, Ioana Golu, Daniela Amzăr, Mărioara Cornianu, Flore Vărcuş, Adrian Vlad, Mihaela Vlad · 2023 · Experimental and Therapeutic Medicine
  42. Endocrine system
    Raymond Y. Huang, Daniel Phung, Gordon Crews, Nasim Sheikh‐Bahaei · 2023 · Elsevier eBooks
  43. Expression of Collagen XIII in Tissues of the Thyroid and Orbit With Relevance to Thyroid-Associated Ophthalmopathy
    Oula Norman, Tuuli Vornanen, Hanna Franssila, Johanna Liinamaa, Elina Karvonen, Tommi Kotkavaara, Vesa‐Matti Pohjanen, Ritva Ylikärppä, Taina A. Pihlajaniemi, Merja Hurskainen et al. · 2024 · Investigative Ophthalmology & Visual Science
  44. Therapeutic role of histone deacetylase inhibition in an in vitro model of Graves' orbitopathy
    Hyeong Ju Byeon, Soo Hyun Choi, Don O. Kikkawa, JaeSang Ko, Jin Sook Yoon · 2024 · Molecular Medicine Reports
  45. Graves’ Ophthalmopathy
    Luigi Bartalena · 2019 · Springer eBooks
  46. Genetics of Graves' Disease
    Alexander Hamilton, Stephen C. L. Gough, Matthew J. Simmonds · 2013 · Encyclopedia of Life Sciences
  47. Autoimmune Thyroid Disease
    Anthony Peter Weetman · 2016 · Elsevier eBooks
  48. A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy
    Parinee Kemchoknatee, Methaphon Chainakul, Duanghathai Tangon, Thansit Srisom · 2022 · Research Square
  49. Current Approach to Graves' Ophthalmopathy: Review
    Arif Yönem, Ferhat Denız, Kamil Başköy, Seyid Ahmet Ay · 2015 · Turkiye Klinikleri Journal of Endocrinology
  50. Not All Low TSH is Graves’ Disease!
    Nikhil M. Bhagwat, Manoj D. Chadha, Ameya S Joshi, Premlata K Varthakavi, Pradip Dalwadi, Bharat R. Sharma, Parimal Tayde, Jagdish A Chavan, Pratibha T Pawal · 2014 · Otorhinolaryngology Clinics - An International Journal
  51. Thyroid-Associated Orbitopathy Occurs in 6% of Patients with Hashimoto's Thyroiditis
    Jacques Orgiazzi · 2016 · Clinical Thyroidology
  52. Doença de Graves: a visão do doente e impacto biopsicossocial - um relato de caso
    Ana Cláudia Cardoso Almeida, Luís Pinho-Costa, Hélder Sousa · 2018 · Revista Portuguesa de Clínica Geral
  53. Acute bilateral eyelid swelling in a 5-year-old child
    Sara Romano, Andrea Taddio, Massimo Maschio, Egidio Barbi, Fulvio Parentin · 2019 · Archives of Disease in Childhood Education & Practice
  54. Preoperative Planning for Thyroid Eye Disease Surgery and Preoperative Checklist
    Mahasweta Mishra, Suryasnata Rath · 2020 · Springer eBooks
  55. The paths of Graves’ disease in the 21st century: precision medicine is closer
    Adriano Namo Cury · 2020 · Archives of Endocrinology and Metabolism
  56. Uso da termografia infravermelha na avaliação de pacientes com oftalmopatia de Graves
    Cínthia Minatel Riguetto · 2018
  57. Graves’ Orbitopathy
    Maria Laura Tanda · 2022 · Encyclopedia of pathology
  58. Epidemiology of Thyroid Eye Disease
    Sathyadeepak Ramesh · 2022 · Springer eBooks
  59. Ophthalmopathy and other influential factors for liver abnormalities in patients with Graves’ disease
    Kalpana Pudasaini, Shaoqin Yang, Zhongshu Ma · 2020
  60. Graves’ Ophthalmopathy
    Lebriz Uslu · 2018 · Springer eBooks
  61. Graves’ Orbitopathy
    Maria Laura Tanda · 2022 · Encyclopedia of pathology
  62. Analysis of N6-methyladenosine modification and immune infiltration characterization in thyroid associated ophthalmopathy
    Nan Yang, Hui Zhu, Junxin Ma, Qing Shao · 2023 · Research Square
  63. Doença de graves, ocorrência e contexto
    R. B. Freitas, Rafaela Lemos Quirino, Jordana Morais De Oliveira, Juliane Honda Gomes, Beatriz Pimenta De Paula, Helaine Bueno Moraes · 2023 · Brazilian Journal of Health Review
  64. Alterações na apresentação inicial da doença de Graves nos últimos 30 anos
    Wanessa de Lourdes Pinto · 2020
  65. Review on Implementing Patient-Centered Care in Primary Health Practice in Qatar
    Walaa Abdulmohsin · 2024 · World Family Medicine Journal/Middle East Journal of Family Medicine
  66. Graves Eye Disease Medical and Surgical Management: A Review
    Yazeed Alshahrani, Abdullah Jallwi Korkoman, Fahad Saud M Alremthi, Hdinan Mohammed J Alsadi, Abdulaziz Braik Saleh AlQarni, Ahmed Alghamdi, Abdullah Alsuayri, Abdullah Alsalooli, Nawaf Saeed O Alshahrani · 2024 · World Family Medicine Journal/Middle East Journal of Family Medicine
  67. Graves’ orbitopathy development in thyroid cancer patients: a 16-year nationwide cohort study in South Korea
    Minjeong Kim, Jooyoung Lee, Yu Been Hwang, Jinmo Kang, Hwa Young Ahn, Jeong Kyu Lee · 2024 · Eye
  68. Glucocorticoid-resistant forms of endocrine ophthalmopathy
    Brovkina Af · 2024 · Russian Annals of Ophthalmology
  69. Tiroid Göz Hastalığında Henle Sinir Lifi Tabakasının Optik Koherens Tomografi ile Değerlendirilmesi
    Mehmet Fatih Kağan Değirmenci, Nazan Acar Eser · 2024 · Medical Journal of Western Black Sea
  70. Thyroid Eye Disease
    Hyun Jun Kim, Trevor Smith, Jeffrey A. Nerad · 2024 · Springer eBooks
  71. Autoimmune Thyroid Disease
    Jadwiga Furmaniak, Ilaria Muller, Colin Mark Dayan, Anthony Peter Weetman · 2025 · Elsevier eBooks
  72. Systemic Adverse Events Associated with Teprotumumab Use: A Population-Based Pharmacovigilance Study
    Victoria C. Leung, Andrew Mihalache, Shayaan Kaleem, Brendan Ka-Lok Tao, Marko M. Popovic, Edsel B. Ing, Georges B. Nassrallah · 2025 · Research Square
  73. A novel nomogram based on orbital MRI parameters for early prediction of dysthyroid optic neuropathy in thyroid-associated ophthalmopathy
    Xianzhi Zhao, Yongran Li, Yanling Lu, Miaozhi Liu, Zeyi Li · 2025 · BMC Ophthalmology
  74. Dysthyroid Optic Neuropathy
    Rebecca Ford · 2025 · Springer eBooks
  75. Additional file 1 of A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy
    Parinee Kemchoknatee, Duanghathai Tangon, Thansit Srisombut · 2023 · Figshare
  76. Association Between Teprotumumab and Hearing Impairment: A Meta-Analysis
    Maxim J Barnett, Maria deMelo, Maria Rego, Carlo Gabriel C. Casipit · 2026 · Cureus
  77. Evaluation of ocular findings in patients with thyroid eye disease: Is medial rectus insertion involvement a clinical activity marker?
    Olgar Öcal, Yusuf Samet Atlıhan, Ozan Özgül, İbrahim Başol, Hatice Deniz İlhan · 2026 · European Journal of Ophthalmology
  78. Assessment of smoking status and management of smoking cessation in moderate to severe Graves’ orbitopathy. A retrospective study of 78 patients
    Camille Collin, Pascal Perney, Luc Jeanjean, I. Raingeard, Ingrid Julier, Olivier Gilly · 2026 · Annales d Endocrinologie
  79. Anterior segment optical coherence tomography angiography in the evaluation of thyroid eye disease: a pilot study
    Swan Kang, Scott Hau, Victoria Barnett, Laxmi Raja, Pearse Andrew Keane, Daniel G. Ezra · 2026 · Orbit
  80. Lonigutamab inhibits hyaluronan production by reducing IGF-1R levels in thyroid eye disease orbital fibroblasts
    Elisa Roztocil, Farha Husain, Charkira C Patrick, Stephen B Thomas, Timothy Mack, Andrew C. Nyborg, Brett D. Welch, Steven E. Feldon, Collynn F. Woeller · 2026 · The Journal of Clinical Endocrinology & Metabolism
  81. Single-Cell Transcriptomic Profiling of Peripheral Blood in a Patient with Progressive Thyroid Eye Disease Following Total Thyroidectomy
    Ainura Mussakulova, Zarina Zhalgasbaeva, Vyacheslav Korobeynikov, Gulnur Zhunussova · 2026 · Genes
  82. Clinical Spectrum of Thyroid Eye Disease in a Tertiary Referral Centre in Eastern India: A Case Series
    Renukha J, Divya Kesarwani, Bhawesh Chandra Saha, Amit Raj, Dev Kant · 2026 · Cureus